Contrary to what's on the surface, PulseOn is not a smartwatch. Developed by a team specializing in high-tech and analysis software for medical use, this end-to-end solution redefines how doctors diagnose, monitor, and treat arrhythmia. Designed to efficiently utilize Optical Heart Rate (OHR) technology, PulseOn, a CE-certified, MDR Class IIa medical device, blends accuracy, science, and convenience.
Easy-to-use, efficient, and optimized for long-term monitoring without daily disturbances, PulseOn is driving significant improvement in the future of healthcare. Additionally, with a technology combining OHR with intermittent ECG for AF (Atrial Fibrillation) screening, it monitors even asymptomatic arrhythmias. Since its first introduction in Finland in 2022, the device has made strides across Europe, Asia, and the Middle East, gaining the attention of doctors and patients with its 24/7 care and precision.
